Clearwater International advises LDC on its investment in Ashtons Hospital Pharmacy Services
Clearwater International has advised private equity investor LDC on its investment in Ashtons Hospital Pharmacy Services (Ashtons), which will enable the existing management team to drive organic growth, further develop its software services, and expand its pharmaceutical warehousing and distribution infrastructure.
In association with the transaction, the Clearwater International Debt Advisory team advised LDC in raising acquisition finance from Silicon Valley Bank (SVB).
Headquartered in Brighton, Ashtons provides medicine management solutions to the UK independent healthcare sector and its services include clinical pharmacy support and the supply of medication.
Through its nationwide network of specialist clinical pharmacists and bespoke software technology, Ashtons’ services help clients to comply with healthcare regulations, professional and best practice requirements regarding medicine management.
In the last three years, Ashtons’ revenues have increased by 70% to reach €21.4m (£18.7m) in 2019, and the company currently employs 90 staff. LDC’s investment will support the business’ organic growth strategy, as it continues to develop its infrastructure and distribution network and enhance its technology platform.